Bratland, Ase <br/><br/>
The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.  [electronic resource] 

 -  Clinical & experimental metastasis  2003 
 - 541-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0262-0898 
<br/><br/><label>Standard No.: </label>10.1023/a:1025860214891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgens--pharmacology<br/>Coculture Techniques<br/>Enzyme-Linked Immunosorbent Assay<br/>Gelatin--metabolism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Metribolone--pharmacology<br/>Prostatic Neoplasms--genetics<br/>RNA, Messenger--genetics<br/>Testosterone Congeners--pharmacology<br/>Tissue Inhibitor of Metalloproteinase-2--genetics<br/>Tumor Cells, Cultured